Cargando…
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors
Genetic modification of many types of mouse tumors to express the B7-1 or B7-2 molecules, natural ligands for the T cell-costimulatory molecule CD28, increases their immunogenicity. However, even after transfection with the B7-1 and/or B7-2 genes, poorly immunogenic tumors fail to elicit and efficie...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192440/ https://www.ncbi.nlm.nih.gov/pubmed/8627175 |
Ejemplares similares
-
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
Publicado: (1994) -
A pathway of costimulation that prevents anergy in CD28- T cells: B7- independent costimulation of CD1-restricted T cells
Publicado: (1995) -
Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes
por: Liu, Shu-Zheng, et al.
Publicado: (2001) -
T Cell Mediated Antibody lnvariance in an Immune
Response Against A Bacterial Carbohydrate Antigen
Requires CD28/B7–1 Costimulation
por: Rademaekers, André, et al.
Publicado: (2001) -
Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4(+) T Cells Independent of the PD-1 Receptor
por: Shin, Tahiro, et al.
Publicado: (2003)